RSEM LP has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are ANAEROPHARMA SCIENCE INC, MACFARLANE BURNET INST FOR MED and AADIGEN LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | Japan | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Medical technology | |
#4 | Organic fine chemistry | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Sapieha Przemyslaw | 13 |
#2 | Beaulieu Normand | 10 |
#3 | Wilson Ariel | 5 |
#4 | Oubaha Malika | 5 |
#5 | Mallette Frédérick Antoine | 3 |
#6 | Spooner Daniel | 2 |
#7 | Mallette Frederick Antoine | 2 |
#8 | Fortier Louis-Philippe | 2 |
#9 | Burman Howard | 2 |
#10 | Normand Beaulieu | 1 |
Publication | Filing date | Title |
---|---|---|
US2020056186A1 | Compositions comprising sasp modulators and senescence attenuators and uses thereof for modulating cellular senescence | |
US2016002641A1 | Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability |